As of 2024-07-27, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -21.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 2,875.35 mil USD. TNDM's TTM EBITDA according to its financial statements is -130.78 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 15.4x | 14.0x |
| Forward P/E multiples | 16.4x - 18.3x | 17.8x |
| Fair Price | (37.63) - (35.69) | (36.66) |
| Upside | -194.0% - -189.1% | -191.5% |
| Date | EV/EBITDA |
| 2024-07-26 | -21.99 |
| 2024-07-25 | -22.28 |
| 2024-07-24 | -23.23 |
| 2024-07-23 | -23.92 |
| 2024-07-22 | -23.56 |
| 2024-07-19 | -23.77 |
| 2024-07-18 | -23.26 |
| 2024-07-17 | -24.74 |
| 2024-07-16 | -25.41 |
| 2024-07-15 | -25.57 |
| 2024-07-12 | -24.96 |
| 2024-07-11 | -24.55 |
| 2024-07-10 | -24.09 |
| 2024-07-09 | -23.43 |
| 2024-07-08 | -23.02 |
| 2024-07-05 | -22.17 |
| 2024-07-03 | -21.87 |
| 2024-07-02 | -21.54 |
| 2024-07-01 | -21.69 |
| 2024-06-28 | -22.10 |
| 2024-06-27 | -22.17 |
| 2024-06-26 | -22.28 |
| 2024-06-25 | -22.04 |
| 2024-06-24 | -21.95 |
| 2024-06-21 | -23.36 |
| 2024-06-20 | -23.23 |
| 2024-06-18 | -23.36 |
| 2024-06-17 | -23.44 |
| 2024-06-14 | -24.59 |
| 2024-06-13 | -24.65 |
| 2024-06-12 | -25.59 |
| 2024-06-11 | -26.11 |
| 2024-06-10 | -26.16 |
| 2024-06-07 | -26.33 |
| 2024-06-06 | -26.69 |
| 2024-06-05 | -27.91 |
| 2024-06-04 | -27.49 |
| 2024-06-03 | -27.88 |
| 2024-05-31 | -27.51 |
| 2024-05-30 | -28.59 |
| 2024-05-29 | -27.76 |
| 2024-05-28 | -28.33 |
| 2024-05-24 | -27.75 |
| 2024-05-23 | -26.74 |
| 2024-05-22 | -27.59 |
| 2024-05-21 | -26.56 |
| 2024-05-20 | -25.53 |
| 2024-05-17 | -25.57 |
| 2024-05-16 | -25.38 |
| 2024-05-15 | -25.60 |